Charak Samhita

Shunthi: Difference between revisions

← Older editNewer edit →
VisualWikitext
Agnivesha (talk | contribs)
Administrators, Editors, Bots, Bureaucrats, Charaksamhita, csmoderator, Interface administrators, Administrators
10,538 edits
No edit summary
Agnivesha (talk | contribs)
Administrators, Editors, Bots, Bureaucrats, Charaksamhita, csmoderator, Interface administrators, Administrators
10,538 edits
Line 66: Line 66:
| 2 || Potency ([[veerya]]) ||Hot (ushna) || Enhances metabolic rate (''Agni'') and clears systemic micro-channels ([[Srotas]])
| 2 || Potency ([[veerya]]) ||Hot (ushna) || Enhances metabolic rate (''Agni'') and clears systemic micro-channels ([[Srotas]])
|-
|-
| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura) || Imparts nourishing, tissue-protective, and rejuvenative (''Rasayana'') long-term effects.
| 3 || Post digestion effect ([[vipaka]]) || Aardrak (Ginger) - Pungent (katu)
Shunthi (Dry Ginger) - Sweet (madhura)  
| Imparts nourishing, tissue-protective, and rejuvenative (''Rasayana'') long-term effects.
|-
|-
| 4 || Qualities ([[guna]])|| Heavy (guru), Rough (ruksha), Sharp (tikshna) || Counteracts the coldness of ''Kapha''.
| 4 || Qualities ([[guna]])|| Aardrak (Ginger) - Heavy (guru), dryness (ruksha), Sharp (tikshna)
Shunthi (Dry Ginger)- Easy to digest (laghu), unctuous (snigdha)
| Ginger counteracts the coldness of ''Kapha,'' Dry ginger acts on dryness of Vata dosha
|-
|-
| 5 || Actions ([[karma]]) || Pacify Vata and Kapha
| 5 || Actions ([[karma]]) || Pacify Vata and Kapha
|Useful in indigestion, swellings, stiffness
|-
|-
| 6 || [[Prabhava]] (Special Action) || Amavataghni / Grahi || Specifically targets rheumatoid conditions; acts as a bowel-binding bio-absorbent.
| 6 || [[Prabhava]] (Special Action) || Amavataghni / Grahi || Specifically targets rheumatoid conditions; acts as a bowel-binding bio-absorbent.
Line 674: Line 679:
|
|
Cha.Sa.[[Chikitsa Sthana]] 15/106
Cha.Sa.[[Chikitsa Sthana]] 15/106
|Agnivruddhiartha  and for alleviating kostha gaya kayu in grahaniroga
|Agnivruddhiartha  and for alleviating koshtha gata vayu in grahaniroga
|-
|-
|148
|148
Line 689: Line 694:
|
|
Cha.Sa.[[Chikitsa Sthana]] 15/132
Cha.Sa.[[Chikitsa Sthana]] 15/132
|As an  ingredient of Nagaradhya churna
|As an  ingredient of Nagaradya churna
|-
|-
|151
|151
|
|
Cha.Sa.[[Chikitsa Sthana]] 15/137
Cha.Sa.[[Chikitsa Sthana]] 15/137
|This drug is  used in treatment of pittajagrahani as an ingredient of Bhunimbadhya churna
|This drug is  used in treatment of pittajagrahani as an ingredient of Bhunimbadya churna
|-
|-
|152
|152
|
|
Cha.Sa.[[Chikitsa Sthana]] 15/142
Cha.Sa.[[Chikitsa Sthana]] 15/142
|As an  ingredient of Kiratadhya churna (Pittaja Grahani chiktsa)
|As an  ingredient of Kiratadya churna (Pittaja Grahani chiktsa)
|-
|-
|153
|153
Line 714: Line 719:
|
|
Cha.Sa.[[Chikitsa Sthana]] 15/177
Cha.Sa.[[Chikitsa Sthana]] 15/177
|As an  ingredient of Pipallimuladhya Kshara
|As an  ingredient of Pipallimuladya Kshara
|-
|-
|156
|156
Line 724: Line 729:
|
|
Cha.Sa.[[Chikitsa Sthana]] 15/89
Cha.Sa.[[Chikitsa Sthana]] 15/89
|As an  ingredient of pancamuladhya ghrit evum churna
|As an  ingredient of pancamuladya ghrita evum churna
|-
|-
|158
|158
Line 806: Line 811:
|177
|177
|Cha.Sa.[[Chikitsa Sthana]] 17/123
|Cha.Sa.[[Chikitsa Sthana]] 17/123
|As an ingredient of  satyadi churna.
|As an ingredient of  shatyadi churna.
|-
|-
|178
|178
Line 1,168: Line 1,173:
|Cha.Sa.[[Chikitsa Sthana]] 30/267
|Cha.Sa.[[Chikitsa Sthana]] 30/267
|Used in the treatment of Phena sanghat, As an  ingredient of Kiratatiktadi kwatha.
|Used in the treatment of Phena sanghat, As an  ingredient of Kiratatiktadi kwatha.
|-
|}
|}


Line 1,192: Line 1,196:
== Current researches ==
== Current researches ==
== Phytochemical Architecture ==
== Phytochemical Architecture ==
The processing of fresh ginger into Shunthi significantly shifts its chemical composition. The primary thermogenic and bioactive markers are phenolic compounds and volatile oils:
The processing of fresh ginger into Shunthi significantly shifts its chemical composition. The primary thermogenic and bioactive markers are phenolic compounds and volatile oils<ref>'''Unuofin, J. O., et al.''' (2021). ''Phytochemical structures and therapeutic potentials of Zingiber officinale compounds.'' Journal of Ethnopharmacology, 273, 113997.</ref>:


* '''Gingerols ([6]-, [8]-, and [10]-gingerol):''' The primary pungent fluid components dominant in fresh ginger.  
* '''Gingerols ([6]-, [8]-, and [10]-gingerol):''' The primary pungent fluid components dominant in fresh ginger.  
* '''Shogaols ([6]-, [8]-, and [10]-shogaol):''' Formed via the thermal dehydration of gingerols during the drying process. '''[6]-shogaol''' exhibits up to twice the anti-inflammatory and antioxidant potency of its precursor, making Shunthi pharmacologically distinct from fresh ginger.
* '''Shogaols ([6]-, [8]-, and [10]-shogaol):''' Formed via the thermal dehydration of gingerols during the drying process. '''[6]-shogaol''' exhibits up to twice the anti-inflammatory and antioxidant potency of its precursor, making Shunthi pharmacologically distinct from fresh ginger.<ref>'''Schepici, G., et al.''' (2021). ''The anti-inflammatory potential of ginger and its constituents in neurodegenerative and arthritic diseases.'' Molecules, 26(18), 5642.</ref>
* '''Zingerone & Paradols:''' Secondary degradation products that contribute significantly to free-radical scavenging.
* '''Zingerone & Paradols:''' Secondary degradation products that contribute significantly to free-radical scavenging.
* '''Volatile Oils (Sesquiterpenes):''' Comprising α-zingiberene, β-sesquiphellandrene, and ar-curcumene, responsible for its distinct aromatic properties.
* '''Volatile Oils (Sesquiterpenes):''' Comprising α-zingiberene, β-sesquiphellandrene, and ar-curcumene, responsible for its distinct aromatic properties.
Line 1,204: Line 1,208:
Shunthi acts as a potent prokinetic and antiemetic agent via central and peripheral mechanisms.  
Shunthi acts as a potent prokinetic and antiemetic agent via central and peripheral mechanisms.  


* '''Antiemetic & Nausea Regulation:''' Clinical meta-analyses validate that oral doses ranging from 500 mg to 1,500 mg daily significantly reduce pregnancy-associated nausea and vomiting (NVP) as well as chemotherapy-induced emesis. The mechanism is mediated via the competitive antagonism of peripheral '''5-HT<sub>3</sub> receptors''' and cholinergic M3 receptors in the gastrointestinal tract.
* '''Antiemetic & Nausea Regulation:''' Clinical meta-analyses validate that oral doses ranging from 500 mg to 1,500 mg daily significantly reduce pregnancy-associated nausea and vomiting (NVP) as well as chemotherapy-induced emesis. The mechanism is mediated via the competitive antagonism of peripheral '''5-HT<sub>3</sub> receptors''' and cholinergic M3 receptors in the gastrointestinal tract.<ref>'''Ernst, E., & Pittler, M. H.''' (2000). ''Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials.'' British Journal of Anaesthesia, 84(3), 367-371.</ref>
* '''Gastroprotective and Prokinetic Action:''' Shunthi accelerates gastric emptying and stimulates gastric acid, bile, and pancreatic enzyme secretion, effectively resolving functional dyspepsia, abdominal bloating, and colicky pain.
* '''Gastroprotective and Prokinetic Action:''' Shunthi accelerates gastric emptying and stimulates gastric acid, bile, and pancreatic enzyme secretion, effectively resolving functional dyspepsia, abdominal bloating, and colicky pain.


Line 1,210: Line 1,214:
In conditions like Rheumatoid Arthritis (''Amavata'') and Osteoarthritis, Shunthi acts as a natural dual-inhibitor of inflammatory cascades.
In conditions like Rheumatoid Arthritis (''Amavata'') and Osteoarthritis, Shunthi acts as a natural dual-inhibitor of inflammatory cascades.


: '''Biochemical Mechanism:''' The active fractions ([6]-shogaol and [6]-gingerol) suppress the activation of Nuclear Factor-kappa B ('''NF-κB'''). This leads to down-regulation of '''COX-2''' (Cyclooxygenase-2) and '''LOX''' (Lipoxygenase) pathways, preventing the synthesis of pro-inflammatory prostaglandins (PGE<sub>2</sub>) and leukotrienes.  
: '''Biochemical Mechanism:''' The active fractions ([6]-shogaol and [6]-gingerol) suppress the activation of Nuclear Factor-kappa B ('''NF-κB'''). This leads to down-regulation of '''COX-2''' (Cyclooxygenase-2) and '''LOX''' (Lipoxygenase) pathways, preventing the synthesis of pro-inflammatory prostaglandins (PGE<sub>2</sub>) and leukotrienes.<ref>'''Jalali, M., et al.''' (2020). ''The effects of ginger supplementation on biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.'' Clinical Nutrition, 39(12), 3598-3606.</ref>


Unlike conventional Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Shunthi exerts these anti-inflammatory and antinociceptive actions without compromising the gastric mucosa, due to its concurrent cytoprotective mucin-stimulating properties.
Unlike conventional Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Shunthi exerts these anti-inflammatory and antinociceptive actions without compromising the gastric mucosa, due to its concurrent cytoprotective mucin-stimulating properties.


=== C. Cardio-Metabolic and Vascular Regulation (Hrudya) ===
=== C. Cardio-Metabolic and Vascular Regulation (Hrudya) ===
Recent clinical and animal trials demonstrate that Shunthi exerts a multi-target protective effect on the cardiovascular and metabolic systems:
Recent clinical and animal trials demonstrate that Shunthi exerts a multi-target protective effect on the cardiovascular and metabolic systems<ref name=":0">'''Wang, J., et al.''' (2017). ''Beneficial effects of ginger on Type 2 Diabetes Mellitus and Metabolic Syndrome: A systems-level overview.'' Phytomedicine, 34, 184-198.</ref>:


* '''Calcium Channel Blockade:''' Shunthi extracts display calcium (Ca<sup>2+</sup>) channel-blocking activity, shifting Ca<sup>2+</sup> dose-response curves to relax vascular smooth muscles. This results in vasodilation and a systemic reduction in blood pressure.
* '''Calcium Channel Blockade:''' Shunthi extracts display calcium (Ca<sup>2+</sup>) channel-blocking activity, shifting Ca<sup>2+</sup> dose-response curves to relax vascular smooth muscles. This results in vasodilation and a systemic reduction in blood pressure.
* '''PPARα Agonism:''' It activates Peroxisome Proliferator-Activated Receptor alpha (PPARα), enhancing fatty acid oxidation in myocytes, thereby attenuating myocardial hypertrophy and reducing risks of atherosclerosis.
* '''PPARα Agonism:''' It activates Peroxisome Proliferator-Activated Receptor alpha (PPARα), enhancing fatty acid oxidation in myocytes, thereby attenuating myocardial hypertrophy and reducing risks of atherosclerosis.
* '''Glycemic Control:''' Meta-analyses show that daily supplementation significantly lowers '''HbA1c''' and fasting blood glucose in Type 2 Diabetes Mellitus patients by improving insulin sensitivity and up-regulating GLUT4 transporters.
* '''Glycemic Control:''' Meta-analyses show that daily supplementation significantly lowers '''HbA1c''' and fasting blood glucose in Type 2 Diabetes Mellitus patients by improving insulin sensitivity and up-regulating GLUT4 transporters.<ref name=":0" />


<pre>
<pre>
Line 1,241: Line 1,245:


* '''Standard Therapeutic Dosage:'''  
* '''Standard Therapeutic Dosage:'''  
** ''Churna (Crude Powder):'' 1 - 3 g per day in divided doses.
** ''Churna (Crude Powder):'' 1 - 3 g per day in divided doses.<ref>'''Ayurvedic Pharmacopoeia of India (API).''' ''Zingiber officinale Rosc. - Rhizome Monograph.'' Part-I, Volume I, Government of India, Ministry of Health and Family Welfare.</ref>
** ''Extract:'' 250 - 500 mg two to three times daily.
** ''Extract:'' 250 - 500 mg two to three times daily.
* '''Adverse Effects:''' Excessive consumption on an empty stomach may occasionally cause mild heartburn, eructation, or gastric irritation in highly sensitive ''Pitta''-dominant individuals.
* '''Adverse Effects:''' Excessive consumption on an empty stomach may occasionally cause mild heartburn, eructation, or gastric irritation in highly sensitive ''Pitta''-dominant individuals.
Line 1,248: Line 1,252:


== References ==
== References ==
# '''Unuofin, J. O., et al.''' (2021). ''Phytochemical structures and therapeutic potentials of Zingiber officinale compounds.'' Journal of Ethnopharmacology, 273, 113997.
[[index.php?title=Category:Database of herbs and minerals| Herbs]]
# '''Jalali, M., et al.''' (2020). ''The effects of ginger supplementation on biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.'' Clinical Nutrition, 39(12), 3598-3606.
# '''Ayurvedic Pharmacopoeia of India (API).''' ''Zingiber officinale Rosc. - Rhizome Monograph.'' Part-I, Volume I, Government of India, Ministry of Health and Family Welfare.
# '''Wang, J., et al.''' (2017). ''Beneficial effects of ginger on Type 2 Diabetes Mellitus and Metabolic Syndrome: A systems-level overview.'' Phytomedicine, 34, 184-198.
# '''Ernst, E., & Pittler, M. H.''' (2000). ''Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials.'' British Journal of Anaesthesia, 84(3), 367-371.
# '''Schepici, G., et al.''' (2021). ''The anti-inflammatory potential of ginger and its constituents in neurodegenerative and arthritic diseases.'' Molecules, 26(18), 5642.
[[Category: Database of herbs and minerals | Herbs]]
Retrieved from "https://www.charakasamhitauptodate.com/index.php?title=Shunthi"